A Prospective Interventional Study on Efficacy of Mifepristone in The Medical Management of Uterine Leiomyomas

Abstract Background: Medical treatment with T. Mifepristone 25mg is an effective method in reducing size, number, volume of myomas and decreasing amount of blood loss, regression of symptoms and decreasing number of surgery. Objective · To determine the efficacy of Mifepristone in the medical management of uterine leiomyomas. · To assess the need of surgical management. Methods: It is a prospective interventional study conducted at Sri Sidharatha Medical Collage, Tumkuru. The effects of Mifepristone 25mg administrations for 3 months was carried out after satisfying inclusion and exclusion criteria, relevant medical history and general physical examination and systemic examination was done. All the patients were subjected to ultrasound abdomen and pelvis to know the location, size, number, volume of myomas and endometrial thickness before the start of treatment Results: There was a statistically significant increase in Hemoglobin after treatment (P < 0.001) and significant reduction in fibroid size post-treatment (P< 0.001). Conclusion: Mifepristone 25mg showed significant reduction in size, volume and improvement in symptoms in a woman with uterine leiomyomas.

Institutions

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2025-06-30
DOI
https://doi.org/10.5281/zenodo.16759260
Primary Topic
Uterine Myomas and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A Prospective Interventional Study on Efficacy of Mifepristone in The Medical Management of Uterine Leiomyomas

Zenodo (CERN European Organization for Nuclear Research)
Uterine Myomas and Treatments
article

A Prospective Interventional Study on Efficacy of Mifepristone in The Medical Management of Uterine Leiomyomas

article en

Abstract

Abstract Background: Medical treatment with T. Mifepristone 25mg is an effective method in reducing size, number, volume of myomas and decreasing amount of blood loss, regression of symptoms and decreasing number of surgery. Objective · To determine the efficacy of Mifepristone in the medical management of uterine leiomyomas. · To assess the need of surgical management. Methods: It is a prospective interventional study conducted at Sri Sidharatha Medical Collage, Tumkuru. The effects of Mifepristone 25mg administrations for 3 months was carried out after satisfying inclusion and exclusion criteria, relevant medical history and general physical examination and systemic examination was done. All the patients were subjected to ultrasound abdomen and pelvis to know the location, size, number, volume of myomas and endometrial thickness before the start of treatment Results: There was a statistically significant increase in Hemoglobin after treatment (P < 0.001) and significant reduction in fibroid size post-treatment (P< 0.001). Conclusion: Mifepristone 25mg showed significant reduction in size, volume and improvement in symptoms in a woman with uterine leiomyomas.

Zenodo (CERN European Organization for Nuclear Research)
Advanced Pharma (US)
Reduced inequalities
Openalex Percentile: Top 41%
Uterine Myomas and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.